Dose escalation of imatinib mesylate can overcome resistance to standard-dose therapy in patients with chronic myelogenous leukemia (Q44189518)
Jump to navigation
Jump to search
scientific article published on 12 September 2002
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Dose escalation of imatinib mesylate can overcome resistance to standard-dose therapy in patients with chronic myelogenous leukemia |
scientific article published on 12 September 2002 |
Statements
1 reference
Dose escalation of imatinib mesylate can overcome resistance to standard-dose therapy in patients with chronic myelogenous leukemia (English)
1 reference
Hagop M Kantarjian
1 reference
Stefan Faderl
1 reference
Jorge Cortes
1 reference
Susan O'Brien
1 reference
Mary Beth Rios
1 reference
Francis Giles
1 reference
Guillermo Garcia-Manero
1 reference
Jianqin Shan
1 reference
Moshe Talpaz
1 reference
Deborah Thomas
1 reference
12 September 2002
1 reference
1 reference
101
1 reference
2
1 reference
473-475
1 reference
Identifiers
1 reference
1 reference